Retroviral transfer of human MDR1 gene to hematopoietic cells: Effects of drug selection and of transcript splicing on expression of encoded P- glycoprotein

Human Gene Therapy

Volumn 10, Issue 13, 1999, Pages 2173-2185

  Licht, Thomas ^a   Aran, Josep M ^a,b   Goldenberg, Sarah K ^a   Vieira, Wilfred D ^a   Gottesman, Michael M ^a   Pastan, Ira ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HOSPITAL DURAN I REYNALS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; COMPLEMENTARY DNA; DAUNORUBICIN; GLUCOSYLCERAMIDASE; GLYCOPROTEIN P; MESSENGER RNA;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL POPULATION; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; GENE TRANSFER; HEMATOPOIETIC CELL; HUMAN; MOUSE; NONHUMAN; PLASMID; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RETROVIRUS; RNA ANALYSIS; RNA SPLICING; TARGET CELL;

3T3 CELLS; ALTERNATIVE SPLICING; ANIMALS; ANTINEOPLASTIC AGENTS; BONE MARROW CELLS; COLCHICINE; DAUNORUBICIN; GENE TRANSFER TECHNIQUES; GENES, MDR; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED C57BL; P-GLYCOPROTEIN; RECOMBINANT PROTEINS; RETROVIRIDAE; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0033199281     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950017167     Document Type: Article

References (50)

1. ARAN, J.M., GOTTESMAN, M.M., and PASTAN, I. (1994). Drug-selected coexpression of human glucocerebrosidase and P-glycoprotein using a bicistronic vector. Proc. Natl. Acad. Sci. U.S.A. 91, 3176-3180.
2. ARAN, J.M., GERMANN, U.A., GOTTESMAN, M.M., and PASTAN, I. (1996a). Construction and characterization of a selectable multidrug resistance-glucocerebrosidase fusion gene. Cytokines Mol. Ther. 2, 47-57.
3. ARAN, J.M., LICHT, T., GOTTESMAN, M.M., and PASTAN, I. (1996b). Complete restoration of glucocerebrosidase deficiency in Gaucher fibroblasts using a bicistronic MDR retrovirus and a new selection strategy. Hum. Gene Ther. 7, 2165-2175.
4. + bone marrow cells. Blood 82, 1975-1980.
5. BREMER, S., HOOF, T., WILKE, BUSCHE, R., SCHOLTE, B., RIORDAN, J.R., MAASS, G., and TUMMLER, B. (1992). Quantitative expression patterns of multidrug-resistance P-glycoprotein (MDR1) and differentially spliced cystic-fibrosis transmembrane-conductance regulator mRNA transcripts in human epithelia. Eur. J. Biochem. 206, 137-149.
6. BUNTING, K.D., GALIPEAU, J., TOPHAM, D., BENAIM, E., and SORRENTINO, B.P. (1998). Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice. Blood 92, 2269-2279.
7. CAPEL, B., HAWLEY, R.G., and MINTZ, B. (1990). Long- and short-lived murine hematopoietic stem cell clones individually identified with retroviral integration markers. Blood 75, 2267-2270.
8. COWAN, K.H., MOSCOW, J.A., HUANG, H., ZUJEWSKl, J., O'SHAUGHNESSY, J., SORRENTINO, B., HINES, K., CARTER, C., SCHNEIDER, E., CUSACK, G., NOONE, M., DUNBAR, C., STEINBERG, W., WILSON, W., GOLDSPIEL, B., READ, E.J., LEITMAN, S., McDONAGH, K., CHOW, C., ABATI, A., CHIANG, Y., CHANG, Y.N., GOTTESMAN, M.M., PASTAN, I., and NIENHUIS, A. (1999). Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients. Clin. Cancer Res. 5, 1619-1628.
9. CROOP, J.M., RAYMOND, M., HABER, D., DEVAULT, A., ARCECI, R.J., GROS, P., and HOUSMAN, D.E. (1989). The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol. Cell. Biol. 9, 1346-1350.
10. CURRIER, S.J., UEDA, K., WILLINGHAM, M.C., PASTAN, I., and GOTTESMAN, M.M. (1989). Deletion and insertion mutants of the multidrug transporter. J. Biol. Chem. 264, 14376-14381.
11. DANOS, O., and MULLIGAN, R.C. (1988). Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. U.S.A. 85, 6460-6464.
12. DEVINE, S.E., HUSSAIN, A., DAVIDE, J.P., and MELERA, P.W. (1991). Full length and alternatively spliced pgp1 transcripts in multidrug-resistant Chinese hamster lung cells. J. Biol. Chem. 266, 4545-4555.
13. DRACH, D., ZHAO, S., DRACH, J., MAHADEVIA, R., GATTRINGER, C., HUBER, H., and ANDREEFF, M. (1992). Subpopulations of normal and peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood 80, 2735-2739.
14. ECKERT, H.G., STOCKSCHLÄDER, M., JUST, U., HEGEWISCH-BECKER, S., GREZ, M., UHDE, A., ZANDER, A., OSTERTAG, W., and BAUM, C. (1996). High-dose multidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vectors. Blood 88, 3407-3415.
15. FRUEHAUF, S., BREEMS, D.A., KNAAN-SHANZER, S., BROUWER, K.B., HAAS, R., LOWENBERG, B., NOOTER, K., PLOEMACHER, R.E., VALERIO, D., and BOESEN, J.J. (1996). Frequency analysis of multidrug resistance-1 gene transfer into human primitive hematopoietic progenitor cells using the cobblestone area-forming cell assay and detection of vector-mediated P-glycoprotein expression by rhodamine-123. Hum. Gene Ther. 7, 1219-1231.
16. GALSKI, H., SULLIVAN, M., WILLINGHAM, M.C., CHIN, K.-V., GOTTESMAN, M.M., PASTAN, I., and MERLINO, G.T. (1989). Expression of a human multidrug resistance cDNA (MDR1) in the bone marrow of transgenic mice: Resistance to daunomycin induced leukopenia. Mol. Cell. Biol. 9, 4357-4363.
17. GERMANN, U.A., CHIN, K.-V., PASTAN, I., and GOTTESMANN, M.M. (1990). Retroviral transfer of a chimeric multidrug resistance-adenosine deaminase gene. FASEB J. 4, 1501-1507.
18. GOTTESMAN, M.M., and PASTAN, I. (1993). Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62, 385-427.
19. GROGAN, T.M., SPIER, C.M., SALMON, S.E., MATZNER, M., RYBSKI, J., WEINSTEIN, R.S., SCHEPER, R.J., and DALTON, W.S. (1993). P-glycoprotein expression in human plasma cell myeloma: Correlation with prior chemotherapy. Blood 81, 490-495.
20. HANANIA, E.G., and DEISSEROTH, A.B. (1994). Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in a mouse gene therapy model. Cancer Gene Ther. 1, 21-25.
21. HANANIA, E.G., GILES, R.E., KAVANAGH, J., FU, S.Q., ELLERSON, D., ZU, Z., WANG, T., SU, Y., KUDELKA, A., RAHMAN, Z., HOLMES, F., HORTOBAGYI, G., CLAXTON, D., BACHIER, C., THALL, P., CHENG, S., HESTER, J., OSTROVE, J.M., BIRD, R.E., CHANG, A., KORBLING, M., SEONG, D., COTE, R., HOLZMAYER, T., MECHETNER, E., HEIMFELD, A., BERENSON, R., BURTNESS, B., EDWARDS, C., BAST, R., ANDREEFF, M., CHAMPLIN, R., and DEISSEROTH, A.B. (1996). Results of MDR-1 vector modification trial indicate that granulocyte-macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy. Proc. Natl. Acad. Sci. U.S.A. 93, 15346-15351.
22. HESDORFFER, C., AYELLO, J., WARD, M., KAUBISCH, A., VAHDAT, L., BALMACEDA, C., GARRETT, T., FETELL, M., REISS, R., BANK, A., and ANTMAN, K. (1998). Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation. J. Clin. Oncol. 16, 165-172.
23. HILDINGER, M., FEHSE, B., HEGEWISCH-BECKER, S., JOHN, J., RAFFERTY, J.R., OSTERTAG, W., and BAUM, C. (1998). Dominant selection of hematopoietic progenitor cells with retroviral MDR1 co-expression vectors. Hum. Gene Ther. 9, 33-42.
24. HOEBEN, R.C., MIGCHIELSEN, A.A., VAN DER JAGT, R.C., VAN ORMOND, H., VAN DER EB, A.J. (1991). Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position. J. Virol. 65, 904-912.
25. KLIMECKI, W.T., FUTSCHER, B.W., GROGAN, T.M., and DALTON, W.S. (1994). P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood 83, 2451-2458.
26. LIGHT, T., AKSENTIJEVICH, I., GOTTESMAN, M.M., and PASTAN, I. (1995). Efficient expression of functional human MDR1 gene in murine bone marrow after retroviral transduction of purified hematopoietic stem cells. Blood 86, 111-121.
27. LIGHT, T., PASTAN, I., GOTTESMAN, M.M., and HERRMANN, F. (1996). The multidrug-resistance gene in gene therapy of cancer and hematopoietic disorders. Ann. Hematol. 72, 184-193.
28. LOO, T.W., and CLARKE, D.M. (1996). The minimum functional unit of human P-glycoprotein appears to be a monomer. J. Biol. Chem. 271, 27488-27492.
29. McLACHLIN, J.R., EGLITIS, M.A., UEDA, K., KANTOFF, P.W., PASTAN, I., ANDERSON, W.F., and GOTTESMAN, M.M. (1990). Expression of a human complementary DNA for the human multidrug resistance gene in murine hematopoietic precursor cells with the use of retroviral gene transfer. J. Natl. Cancer Inst. 82, 1260-1263.
30. METZ, M.Z., BEST, D.M., and KANE, S.E. (1995). Harvey murine sarcoma virus/MDR1 retroviral vectors: Efficient virus production and foreign gene transduction using MDR1 as selectable marker. Virology 208, 634-643.
31. METZ, M.Z., MATSUMOTO, L., WINTERS, K.A., DOROSHOW, J.H., and KANE, S.E. (1996). Bicistronic and two-gene retroviral vectors for using MDR1 as a selectable marker and a therapeutic gene. Virology 217, 230-241.
32. MICKISCH, G.H., LICHT, T., MERLINO, G.T., GOTTESMAN, M.M., and PASTAN, I. (1991). Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: Efficacy, potency and toxicity. Cancer Res. 51, 5417-5424.
33. L. J. Biol. Chem. 271, 6306-6312.
34. MOSCOW, J.A., HUANG, H., CARTER, C, HINES, K., ZUJEWSKI, J., CUSACK, G., CHOW, C., VENZON, E., SORRENTINO, B., CHIANG, Y.W., GOLDSPIEL, B., LEITMAN, S., READ, E.J., ABATI, A., GOTTESMAN, M.M., PASTAN, I. SELLERS, S., DUNBAR, C., and COWAN, K.H. (1999). Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy. Blood 94, 52-61.
35. NOLTA, J.A., DAO, M.A., WELLS, S., SMOGORZEWSKA, E.M., and KOHN, D.B. (1996). Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 93, 2414-2419.
36. O'SHAUGHNESSY, J.A., COWAN, K.H., NIENHUIS, A.W., McDONAGH, K.T., SORRENTINO, B.P., DUNBAR, C.E., CHIANG, Y., WILSON, W., GOLDSPIEL, B., KOHLER, D., COTTLER-FOX, M., LEITMAN, S.F., GOTTESMAN, M.M., PASTAN, I., DENICOFF, A., NOONE, M., and GRESS, R. (1994). Retroviral mediated transfer to the human multidrug resistance gene (MDR-1) into hematopoietic stem cells during autologous transplantation after intensive chemotherapy for metastatic breast cancer. Hum. Gene Ther. 5, 891-911.
37. PASTAN, I., and GOTTESMAN, M.M. (1987). Multiple-drug resistance in human cancer. N. Engl. J. Med. 316, 1388-1393.
38. PASTAN, I., GOTTESMAN, M.M., UEDA, K., LOVELACE, E., RUTHERFORD, A.V., and WILLINGHAM, M.C. (1988). A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc. Natl. Acad. Sci. U.S.A. 85, 4486-4490.
39. PETERSEN, R., KEMPLER, G., and BARKLIS, E. (1991). A stem cell-specific silencer in the primer-binding site of a retrovirus. Mol. Cell. Biol. 11, 1214-1221.
40. PODDA, S., WARD, M., HIMELSTEIN, A., RICHARDSON, C., DE LA FLOR-WEISS, E., SMITH, L., GOTTESMAN, M.M., PASTAN, I., and BANK, A. (1992). Transfer and expression of the human multiple drug resistance gene into live mice. Proc. Natl. Acad. Sci. U.S.A. 89, 9676-9680.
41. RICHARDSON, C., and BANK, A. (1995). Preselection of transduced murine hematopoietic stem cell populations leads to increased long-term stability and expression of the human multiple drug resistance gene. Blood 86, 2579-2589.
42. RIO, D.C. (1993). Splicing of pre-mRNA: Mechanism, regulation and role in development. Curr. Opin. Genet. Dev. 3, 574-584.
43. SAFA, A.R., STERN, R.K., CHOI, K., AGRESTI, M., TAMAI, I., MEHTA, N.D., and RONINSON, I.B. (1990). Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185 → Val-185 substitution in P-glycoprotein. Proc. Natl. Acad. Sci. U.S.A. 87, 7225-7229.
44. SALMON, S.E., GROGAN, T.M., MILLER, T., SCHEPER, R., and DALTON, W.S. (1989). Prediction of doxorubicin resistance in vitro in melanoma, lymphoma, and breast cancer by P-glycoprotein staining. J. Natl. Cancer Inst. 81, 696-701.
45. SOKOLIC, R.A., SEKHSARIA, S., SUGIMOTO, Y., WHITING-THEOBALD, N., LINTON, G.F., LI, F., GOTTESMAN, M.M., and MALECH, H.L. (1996). A bicistronic retrovirus vector containing a picornavirus internal ribosome entry site allows for correction of X-linked CGD by selection for MDR1 expression. Blood 87, 42-50.
46. SORRENTINO, B.P., BRANDT, S.J., BODINE, D., GOTTESMAN, M., PASTAN, I., CLINE, A., and NIENHUIS, A.W. (1992). Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 257, 99-103.
47. SORRENTINO, B.P., McDONAGH, K.T., WOODS, D., and ORLIC, D. (1995). Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice. Blood 86, 491-501.
48. SUGIMOTO, Y., AKSENTIJEVICH, I., MURRAY, G., BRADY, R.O., PASTAN, I., and GOTTESMAN, M.M. (1995). Retroviral coexpression of a multidrug-resistance gene (MDR1) and human alpha-galactosidase A for gene therapy of Fabry disease. Hum. Gene Ther. 6, 905-915.
49. VAN DER BLIEK, A.M., BAAS, F., TEN HOUTE DE LANGE, T., KOOIMAN, P.M., VAN DER VELDE-KOERTS, T., AND BORST, P. (1987). The human mdr3 gene encodes a novel P-glycoprotein homologue and gives rise to alternatively spliced mRNAs in liver. EMBO J. 6, 3325-3331.
50. ZHOU, Y., ARAN, J., GOTTESMAN, M.M., and PASTAN, I. (1998). Co-expression of human adenosine deaminase and multidrug resistance using a bicistronic vector. Hum. Gene Ther. 9, 287-293.